… therapy, thereby enabling patients to achieve optimal benefits. … the most common
erlotinib-related skin disorders in patients with … skin disorders reported with erlotinib are acneiform …

… erlotinib-related skin rash, data from 485 patients enrolled onto the phase III randomized trial
(BR.21) of erlotinib … NSCLC show that skin rash occurred in 75% of the patient population [7]…

… of rash and response and/or survival, making rash a … of erlotinib-induced skin rash and
establishes a treatment strategy to help treat dermatologic adverse events and allow patients to …

… Rash is associated with a good therapeutic response. We aimed at the evaluation of rash
as a predictor of therapeutic effect of erlotinib in patients … Totally 184 patients with advanced …

… that by increasing the dose of erlotinib until the development of a grade 2 or tolerable skin
rash, response and survival would be improved. This study of erlotinib in the first-line setting of …

… side effect in patients receiving erlotinib is skin rash, as discussed … Skin rash often hampers
significantly the quality of life and … the pathogenesis of the erlotinib induced skin rash and we …

… predictive effect of the erlotinib/O-desmethyl-erlotinib ratio to skin rash in terms of PFS and …
of erlotinib/O-desmethyl-erlotinib ratio as biomarker in comparison to skin rash might be that it …

… EGFR mutation-negative patients who presented with a skin rash … of erlotinib depending
on the presence of a rash, we suggest that erlotinib may be more effective in patients with a rash …

… of skin pigmentation would be associated with higher frequency and severity … erlotinib
rash. Methods: We conducted a retrospective chart review of 42 patients undergoing erlotinib …

… Here, we describe two NSCLC patients who received erlotinib therapy and developed a skin
rash, … Our results suggest that the mechanism of the skin rash development after erlotinib …